Clinical trial supports use of novel preventive therapy for dangerous swelling disorder

(Massachusetts General Hospital) A clinical trial for a new drug to prevent attacks of hereditary angioedema -- a rare disorder characterized by recurrent swelling of tissues in the face, hands, gastrointestinal tract and airway -- has had promising results.